Mergon Group, the Castlepollard plastics manufacturer, has completed the acquisition of Inmo Tech, a specialist injection moulder in Enniscrone, Co Sligo. Announced on 1 October 2026, the deal gives Mergon a dedicated healthcare moulding site in the North-West, where over 80% of Inmo Tech's customers are in medical and healthcare. The price was not disclosed.
The deal was confirmed in a Mergon Group release and by its private equity backer, Elysian Capital, both dated 1 October 2026. Inmo Tech confirmed it on its website.
- Deal completed: Mergon Group announced on 1 October 2026 that it has completed the acquisition of Inmo Tech. Price and terms were not disclosed.
- The target: a contract injection moulder founded in 1985 at Cloona, Enniscrone, Co Sligo, certified by the NSAI to ISO 13485:2016.
- Healthcare focus: Inmo Tech says over 80% of its customers are in the medical and healthcare sectors.
- The buyer: Mergon employs over 1,200 people in Ireland, the UK, the Czech Republic, the US and Mexico.
- Second bolt-on: Elysian Capital says this is Mergon's second acquisition since it invested in 2019, after Weltonhurst in Blackburn in 2022.
1. What was announced
Mergon Group said it "has completed the acquisition of Inmo Tech Limited", describing a deal that "adds specialist injection moulding expertise, an experienced team and a strong platform for further growth in healthcare." The company is registered with the Companies Registration Office as Inmo-Tech Limited (CRO no. 106909), and Elysian's release uses the hyphenated name.
Neither release gives a price, deal structure or advisers, and no jobs figure, rebrand or integration timeline was announced.
Stéphane Maravel, CEO of Mergon Group, said: "Inmo Tech has built a strong reputation for specialist injection moulding in healthcare, supported by deep technical knowledge and a committed team. The business is an excellent strategic fit for Mergon."
Brendan Cunningham, General Manager of Inmo Tech, said: "Joining Mergon Group is an important new chapter for Inmo Tech. Mergon shares our commitment to customers, quality and technical excellence. Its scale, resources and international experience will support the continued development of the business while providing a strong home for our employees and customers."
2. Mergon and Inmo Tech at a glance
| Item | Mergon Group | Inmo Tech |
|---|---|---|
| Base | Castlepollard, Co Westmeath | Cloona, Enniscrone, Co Sligo |
| Founded | 1981, by plastics engineer Pat Beirne | 1985 (incorporated 26 April 1985) |
| Leadership | Stéphane Maravel, CEO (appointment announced August 2026) | Brendan Cunningham, General Manager |
| Ownership before the deal | Elysian Capital majority stake since December 2019 | Described on its website as "owner managed" |
| Footprint | Operations in Ireland, the USA, the Czech Republic, the UK and Mexico | One 30,000 sq ft site running 24/7 |
| Employees | Over 1,200 (June 2026) | Not published |
| Markets | Automotive, healthcare and industrial; named healthcare customers include Abbott, Beckman Coulter and Pfizer | Over 80% medical/healthcare; also electrical, building, appliances |
| Quality system | Not stated | NSAI certified to ISO 13485:2016; operates to 21 CFR 820 |
| Revenue | Not published | Not published (files as a small company with the CRO) |
3. What Inmo Tech brings
According to its website, Inmo Tech runs more than 20 injection moulding machines from 50 to 200 tonnes, all fitted with robots, alongside a Class 100,000 cleanroom, a quality, metrology and testing lab and a mould-modification shop. Services include IQ/OQ/PQ validation, scientific moulding with cavity-pressure monitoring, mould maintenance and prototype parts.
Those pages date from 2023, so equipment counts may have changed. Inmo Tech has not published customer names or headcount.
4. Why Mergon wants it
Mergon said the deal is intended "to strengthen its healthcare capabilities and support its long-term growth ambitions in the sector", and that Inmo Tech brings "complementary injection moulding expertise, an established manufacturing facility and a highly experienced team." Inmo Tech will be able to draw on the group's "engineering, automation, product development, project management and global manufacturing capabilities."
James Cunningham, partner at Elysian, said: "We are pleased to support the acquisition of Inmo-Tech which is the second bolt on since we invested in Mergon. The first, Mergon UK, demonstrated management's ability to extend the geographic reach of the business while Inmo-Tech shows the opportunities to build out in a sector." Mergon UK began as Weltonhurst Ltd, a Blackburn blow moulder bought in 2022.
5. What it means for medtech manufacturing in the West and North-West
The deal brings an Irish-founded contract moulder into an Irish-headquartered group. A single-site Sligo supplier joins a group that already serves large healthcare customers in Europe and North America. Mergon has ties to the Irish medtech sector: its former CEO, Pádhraic McGinn, was elected Chair of the Irish Medtech (Ibec) Board in 2024.
Sligo already has some precision moulding for medtech. In 2019 GW Plastics announced more than 200 jobs at a Sligo site focused on surgical components, diagnostic devices and drug delivery, with IDA Ireland support, Silicon Republic reported. That is a 2019 figure.
The local impact is not yet known. Mergon has given no headcount, investment plan or timeline for the site, and we found no IDA Ireland or Enterprise Ireland involvement. A "150 new jobs" figure linked to this deal online actually comes from Mergon's 2022 Mexico plant announcement.
6. Frequently Asked Questions (FAQ)
Q: Who bought Inmo Tech?
A: Mergon Group of Castlepollard, Co Westmeath, majority owned by London private equity firm Elysian Capital since 2019.
Q: How much did Mergon pay?
A: The price was not disclosed.
Q: What does Inmo Tech make?
A: Precision plastic components, moulded under contract, including in a cleanroom. Over 80% of its customers are in medical and healthcare.
Q: Will the deal create jobs in Enniscrone?
A: No jobs figure was announced.
Q: Is this Mergon's first acquisition?
A: No. Elysian describes it as the second bolt-on since its investment, after Weltonhurst in Blackburn, UK, in 2022, which now operates as Mergon UK.
Conclusion and Outlook
The deal value was not published, but the strategic logic is clear: Mergon gains an ISO 13485-certified, healthcare-focused moulding site, and Inmo Tech gains the backing of a group with more than 1,200 staff in five countries. Headcount, investment and plans for the Enniscrone site have not yet been published. We will update this article if Mergon announces them.
Sources: Mergon Group release, "Mergon acquires Inmo Tech, strengthening its healthcare manufacturing capabilities in Ireland" (1 October 2026); Elysian Capital release (1 October 2026); Inmo Tech website, inmotech.ie (accessed 13 October 2026); Mergon Group news posts (2 December 2022, 29 August 2023, 15 March 2024, 8 June 2026, 7 August 2026); CRO open data (accessed 13 October 2026); Irish Times (Charlie Taylor, 19 December 2019); Addleshaw Goddard (March 2022); Silicon Republic (Jenny Darmody, 22 February 2019).
Cover photo: injection moulding at Inmo Tech, Enniscrone. Credit: Inmo Tech.
